[
  {
    "ts": null,
    "headline": "8 March Raises From Duke's 0.5% To Broadcom At 11.3%",
    "summary": "8 March Raises From Duke's 0.5% To Broadcom At 11.3%",
    "url": "https://finnhub.io/api/news?id=aad2e6a77de0e5842318e13d271638505c337a03c1b0b4a01eea27365555d2c6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744581073,
      "headline": "8 March Raises From Duke's 0.5% To Broadcom At 11.3%",
      "id": 133902759,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=aad2e6a77de0e5842318e13d271638505c337a03c1b0b4a01eea27365555d2c6"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Don't Make The Same Mistake Buying This Dip Again",
    "summary": "Pfizerâs multi-year lows reflect headwinds, lack of catalysts, and fading appeal to both growth and defensive investors. Read why PFE stock is a hold.",
    "url": "https://finnhub.io/api/news?id=7f9e5dc205b292df931d05c55dff67cf8a7e22f7cc3bb107f333125430930994",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744543800,
      "headline": "Pfizer: Don't Make The Same Mistake Buying This Dip Again",
      "id": 133900741,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizerâs multi-year lows reflect headwinds, lack of catalysts, and fading appeal to both growth and defensive investors. Read why PFE stock is a hold.",
      "url": "https://finnhub.io/api/news?id=7f9e5dc205b292df931d05c55dff67cf8a7e22f7cc3bb107f333125430930994"
    }
  },
  {
    "ts": null,
    "headline": "SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade)",
    "summary": "SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade)",
    "url": "https://finnhub.io/api/news?id=c263ba91fd2f5f97e2245d7d6f38efdbee4b461a2189aef3eb9e8358f6ec77e0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744535700,
      "headline": "SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade)",
      "id": 133900317,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=c263ba91fd2f5f97e2245d7d6f38efdbee4b461a2189aef3eb9e8358f6ec77e0"
    }
  },
  {
    "ts": null,
    "headline": "Buy 9 'Safer' Dividend Dogs Of 23 April Barron's Better Bets Than T-Bills",
    "summary": "Discover top BBB dividend dogs with projected average net gains of 43.38% by 2026. Explore investment picks like Pfizer & Best Buy.",
    "url": "https://finnhub.io/api/news?id=7c801437a328e72413592a214d21c39b9acc7b0970d2f007ea2a7712bb3a6be1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744530107,
      "headline": "Buy 9 'Safer' Dividend Dogs Of 23 April Barron's Better Bets Than T-Bills",
      "id": 133899955,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/500431832/image_500431832.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover top BBB dividend dogs with projected average net gains of 43.38% by 2026. Explore investment picks like Pfizer & Best Buy.",
      "url": "https://finnhub.io/api/news?id=7c801437a328e72413592a214d21c39b9acc7b0970d2f007ea2a7712bb3a6be1"
    }
  }
]